Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37

European Journal of Pharmacology

Volumn 818, Issue , 2018, Pages 294-299

  Conti, Pio ^a   Caraffa, Alessandro ^b   Ronconi, Gianpaolo ^c   Kritas, Spiros K ^d   Mastrangelo, Filiberto ^e   Tettamanti, Lucia ^f   Theoharides, Theoharis C ^g  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY OF FOGGIA   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Intestine; Mast cells; Mucosal immunity

Indexed keywords

CHYMASE; CORTICOTROPIN RELEASING FACTOR; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 37; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTENSIN; RANTES; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 1;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENTERITIS; HISTAMINE RELEASE; HUMAN; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; IMMUNOLOGY; INFLAMMATION; INTESTINE; METABOLISM;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; INTERLEUKIN-1; INTESTINES; MAST CELLS;

EID: 85032673095     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.09.044     Document Type: Review

References (72)

1. Alysandratos, K.D., Asadi, S., Angelidou, A., et al. Neurotensin and CRH interactions augment human mast cell activation. PLoS One, 7, 2012, e48934.
2. Banchereau, J., Pascual, V., O'Garra, A., From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat. Immunol. 13:10 (2012), 925–931.
3. Boeckxstaens, G.E., Neuroimmune interaction in the gut: from bench to bedside. Verh. K. Acad. Geneeskd. Belg. 68:5–6 (2006), 329–355.
4. Bueno, L., Protease activated receptor 2: a new target for IBS treatment. Eur. Rev. Med. Pharmacol. Sci. 12:Suppl. 1 (2008), 95–102.
5. Buhner, S., Schemann, M., Mast cell-nerve axis with a focus on the human gut. Biochim. Biophys. Acta 1822:1 (2012), 5–92.
6. Caraffa, A., Spinas, E., Kritas, S.K., Lessiani, G., Ronconi, G., Saggini, A., et al. Endocrinology of the skin: intradermal neuroimmune network, a new frontier. J. Biol. Regul. Homeost. Agents 30:2 (2016), 339–343.
7. Caraffa, Al, Varvara, G., Spinas, E., Kritas, S.K., Lessiani, G., Ronconi, G., et al. Is vitamin E an anti-allergic compound?. J. Biol. Regul. Homeost. Agents(1), 2016, 11–15.
8. Carinci, F., Lessiani, G., Spinas, E., Kritas, S.K., Ronconi, G., Caraffa, A., Conti, P., Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity, new frontiers. J. Biol. Regul. Homeost. Agents 30:4 (2016), 45–950.
9. Carraway, R., Leeman, S.E., The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248:19 (1973), 6854–6861.
10. Caughey, G.H., Mast cell proteases as protective and inflammatory mediators. Adv. Exp. Med. Biol. 716 (2011), 212–234.
11. Conti, C., Caraffa, A., Kritas, S.K., Ronconi, G., Fulcheri, M., Alexithymia and its relationships with inflammatory response mediated by IL-1 family members. J. Biol. Regul. Homeost. Agents 31:1 (2017), 21–28.
12. Conti, P., Pang, X., Boucher, W., Letourneau, R., Reale, M., Barbacane, R.C., et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:11 (1997), 4120–4127.
13. Conti, P., Reale, M., Barbacane, R.C., Letourneau, R., Theoharides, T.C., Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice, lack of effects in genetically mast cell-deficient W/WV mice. FASEB J. 12:15 (1998), 1693–1700.
14. Conti, P., Caraffa, Al, Kritas, S.K., Ronconi, G., Lessiani, G., Toniato, E., Theoharides, T.C., Mast cell, pro-inflammatory and anti-inflammatory, Jekyll and Hyde: the story continues. J. Biol. Regul. Homeost. Agents 31:2 (2017), 263–267.
15. Conti, P., Ronconi, G., Caraffa, A., Lessiani, G., Duraisamy, K., IL-37 a new IL-1 family member emerges as a key suppressor of asthma mediated by mast cells. Immunol. Invest 46:3 (2017), 239–250, 10.1080/08820139.2016.1250220.
16. Conti, P., Lessiani, G., Kritas, S.K., Ronconi, G., Caraffa, A., Theoharides, T.C., Mast cells emerge as mediators of atherosclerosis, special emphasis on IL-37 inhibition. Tissue Cell. 49:3 (2017), 393–400, 10.1016/j.tice.2017.04.002.
17. van Diest, S.A., Stanisor, O.I., Boeckxstaens, G.E., et al. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim. Biophys. Acta 1822:1 (2012), 74–84.
18. Dinan, T.G., Quigley, E.M., Ahmed, S.M., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome, plasma cytokines as a potential biomarker?. Gastroenterology 130:2 (2006), 304–311.
19. Eskandari, N., Tashrifi, F., Bastan, R., Andalib, A., Yousefi, Z., Peachell, P.T., Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells. Int. J. Immunopathol. Pharmacol. 29:4 (2016), 654–665.
20. Félix, M.N., Goy-Thollot, I., Walton, S.R., et al. Effects of etomidate in the adrenal and cytokine responses to hemorrhagic shock in rats. Eur. J. Inflamm., 2016, 147–161.
21. Furuya, S., Furuya, K., Roles of substance P and ATP in the subepithelial fibroblasts of rat intestinal villi. Int. Rev. Cell. Mol. Biol. 304 (2013), 133–189.
22. Galkina, E., Ley, K., Leukocyte influx in atherosclerosis. Curr. Drug Targets 8:12 (2007), 1239–1248.
23. Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M., Tsai, M., Mast cells as “tunable” effector and immunoregulatory cells, recent advances. Ann. Rev. Immunol. 23 (2005), 749–786.
24. Galli, S.J., Tsai, M., Marichal, T., Tchougounova, E., Reber, L.L., Pejler, G., Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv. Immunol. 126 (2015), 45–127.
25. Giembycz, M.A., Phosphodiesterase 4 inhibitors and the treatment of asthma, where are we now and where do we go from here?. Drugs 59:2 (2000), 193–212.
26. Gilfillan, A.M., Beaven, M.A., Regulation of mast cell responses in health and disease. Crit. Rev. Immunol. 31:6 (2011), 475–529.
27. Gui, X.Y., Mast cells, a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J. Gastroenterol. Hepatol. 13:10 (1998), 980–989.
28. Guo, M.J., Investigation into early postoperative inflammatory small bowel obstruction by applying gastrointestinal decompression. J. Biol. Regul. Homeost. Agents 30:3 (2016), 811–814.
29. Halliez, M.C., Buret, A.G., Gastrointestinal parasites and the neural control of gut functions. Front. Cell. Neurosci., 9, 2015, 452.
30. Halova, I., Draber, P., Tetraspanins and transmembrane adaptor proteins as plasma membrane organizers—mast cell case. Front. Cell. Dev. Biol., 4, 2016, 43.
31. Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43:1 (2015), 29–40.
32. He, S.H., Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 10:3 (2004), 309–318.
33. + T cell responses to intestinal commensal bacteria. Nature 498:7452 (2013), 113–117.
34. Huang, X., Zhao, W., Hu, D., Han, X., Wang, H., Yang, J., Xu, Y., Li, Y., Yao, W., Chen, C., Resveratrol efficiently improves pulmonary function via stabilizing mast cells in a rat intestinal injury model. Life Sci. 185 (2017), 30–37, 10.1016/j.lfs.2017.07.018.
35. Jacob, C., Yang, P.C., Darmoul, D., Amadesi, S., et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J. Biol. Chem. 280:36 (2005), 31936–31948.
36. Jang, T.Y., Kim, Y.H., Interleukin-33 and mast cells bridge innate and adaptive immunity, from the allergologist's perspective. Int. Neurourol. J. 19:3 (2015), 142–150.
37. Karimi, K., Redegeld, F.A., Blom, R., Nijkamp, F.P., Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol. 28:6 (2000), 626–634.
38. Kokkotou, E., Torres, D., Moss, A.C., O'Brien, M., Grigoriadis, D.E., Karalis, K., Pothoulakis, C., Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J. Immunol. 177:5 (2006), 3355–3361.
39. Kuna, P., Cytokines in allergic inflammation. Pol. Merkur Lek. 14:84 (2003), 497–499.
40. Kutukculer, N., Azarsiz, E., Aksu, G., Karaca, N.E., CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency. Int. J. Immunopathol. Pharmacol. 29:2 (2016), 241–251.
41. Lopetuso, L.R., Chowdhry, S., Pizarro, T.T., Opposing functions of classic and novel IL-1 family members in gut health and disease. Front. Immunol., 4, 2013, 181.
42. Loppnow, H., Werdan, K., Buerke, M., Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun. 14:2 (2008), 63–87.
43. Matin, N., Tabatabaie, O., Falsaperla, R., Pavone, P., Serra, A., Cocuzza, S., et al. Efficacy and safety of omalizumab in paediatric age, an update of literature data. J. Biol. Regul. Homeost. Agents 30:2 (2016), 579–584.
44. McInnes, I.B., Leukotrienes, mast cells, and T cells. Arthritis Res. Ther. 5:6 (2003), 288–289.
45. Miller, H.R., Pemberton, A.D., Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105:4 (2002), 375–390.
46. Morrison, Di. Tommaso, Carinci, M.C., Lessiani, F., Spinas, G., Kritas, E., Ronconi, S.K., Caraffa, G., Al, Conti, P., Fibromyalgia and bipolar disorder, extent of comorbidity and therapeutic implications. J. Biol. Regul. Homeost. Agents 31:1 (2017), 17–20.
47. Nakayama, S., Yokote, T., Hiraoka, N., Nishiwaki, U., Hanafusa, T., Nishimura, Y., et al. Role of mast cells in fibrosis of classical Hodgkin lymphoma. Int. J. Immunopathol. Pharmacol. 29:4 (2016), 603–611.
48. Owlia, M.B., Tissue response to injury, Ubiquity of cell injury makes inflammation-mediated disorders ubiquitous. Eur. J. Inflamm. 14 (2016), 212–213.
49. Palaska, I., Gagari, E., Theoharides, T.C., The effects of P. gingivalis and E. coli LPS on the expression of proinflammatory mediators in human mast cells and their relevance to periodontal disease. J. Biol. Regul. Homeost. Agents 30:3 (2016), 655–664.
50. Petra, A.I., Panagiotidou, S., Hatziagelaki, E., Stewart, J.M., Conti, P., Theoharides, T.C., Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin. Ther. 37:5 (2015), 984–995.
51. Ray, A., Khare, A., Krishnamoorthy, N., Qi, Z., Ray, P., Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3:3 (2010), 216–229.
52. Romagnani, S., The role of lymphocytes in allergic disease. J. Allergy Clin. Immunol. 105:3 (2000), 399–408.
53. Rosenbaum, J.T., Choi, D., Wong, A., et al. The role of the immune response in the pathogenesis of thyroid eye disease, a reassessment. PLoS One, 10(9), 2015, e0137654.
54. Sahemey, R., Malliaras, P., Lewis, J.S., Michael, G.J., Shortland, P., Morrissey, D., Maffulli, N., Tendinopathic supraspinatus tenocytes may have a neuroendocrine-like function, secreting CGRP, SP and VEGF, a pilot immunohistochemistry study. J. Biol. Regul. Homeost. Agents 30:4 Suppl. 1 (2016), 219–227.
55. Shea-Donohue, T., Stiltz, J., Zhao, A., Notari, L., Mast cells. Curr. Gastroenterol. Rep. 12:5 (2010), 349–357.
56. da Silva, E.Z., Jamur, M.C., Oliver, C., Mast cell function, a new vision of an old cell. J. Histochem. Cytochem. 62:10 (2014), 698–738.
57. Sismanopoulos, N., Delivanis, D.A., Mavrommati, D., Hatziagelaki, E., Conti, P., Theoharides, T.C., Do mast cells link obesity and asthma?. Allergy 68:1 (2013), 8–15.
58. Stone, K.D., Prussin, C., Metcalfe, D.D., IgE, Mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 125:2 Suppl. 2 (2010), S73–S80.
59. Straub, R.H., Wiest, R., Strauch, U.G., Härle, P., Schölmerich, J., The role of the sympathetic nervous system in intestinal inflammation. Gut 55:11 (2006), 1640–1649.
60. Taracanova, A., Alevizos, M., Karagkouni, A., Weng, Z., Norwitz, E., Conti, P., Leeman, S.E., Theoharides, T.C., SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. Proc. Natl. Acad. Sci. USA, 114(20), 2017, 10.1073/pnas.1524845114 (E4002-E4009).
61. Theoharides, T.C., Doyle, R., Autism, gut-blood-brain barrier, and mast cells. J. Clin. Psychopharmacol. 28:5 (2008), 479–483.
62. Theoharides, T.C., Donelan, J., Kandere-Grzybowska, K., Konstantinidou, A., The role of mast cells in migraine pathophysiology. Brain Res. Brain Res. Rev. 49:1 (2005), 65–76.
63. Theoharides, T.C., Kempuraj, D., Tagen, M., Conti, P., Kalogeromitros, D., Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217 (2007), 65–78.
64. Theoharides, T.C., Rozniecki, J.J., Sahagian, G., et al. Impact of stress and mast cells on brain metastases. J. Neuroimmunol. 205:1–2 (2008), 1–7.
65. Theoharides, T.C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K.D., Kalogeromitros, D., Asadi, S., Stavrianeas, N., Peterson, E., Leeman, S., Conti, P., IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc. Natl. Acad. Sci. USA 107:9 (2010), 4448–4453.
66. Vanuytsel, T., van Wanrooy, S., Vanheel, H., et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 63:8 (2014), 1293–1299.
67. Wang, X.T., Lv, M., Guo, H.Y., Effects of epidural block combined with general anesthesia on antitumor characteristics of T helper cells in hepatocellular carcinoma patients. J. Biol. Regul. Homeost. Agents 30:1 (2016), 67–77.
68. Yang, L., Ting, Y., Shen, Y., et al. 17β-estradiol modulates the viability, phenotype, endocytosis, and inflammatory cytokine expression of RAW264.7 macrophages. Eur. J. Inflamm. 1 (2016), 10–17.
69. Yu, L.C., Intestinal epithelial barrier dysfunction in food hypersensitivity. J. Allergy (Cairo), 2012, 596081.
70. Yu, L.C., Perdue, M.H., Role of mast cells in intestinal mucosal function, studies in models of hypersensitivity and stress. Immunol. Rev. 179 (2001), 61–73.
71. Żbikowska-Gotz, M., Pałgan, K., Gawrońska-Ukleja, E., et al. Expression of IL-17A concentration and effector functions of peripheral blood neutrophils in food allergy hypersensitivity patients. Int. J. Immunopathol. Pharmacol. 29:1 (2016), 90–98.
72. Zhan, Q., Zeng, Q., Song, R., Zhai, Y., Xu, D., Fullerton, D.A., Dinarello, C.A., Meng, X., IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells. Mol. Med., 23, 2017, 10.2119/molmed.2017.00022.